Clinical Trial Update: Thyroid Hormone Replacement for Subclinical Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating thyroid hormone replacement for subclinical hypothyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subclinical Hypothyroidism

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Subclinical Hypothyroidism | Phase 4 | Status: COMPLETED